Abstract
From 50 published cases of hepatocellular adenoma (HCA) in glycogen storage disease, type I (GSD I) some characteristic features may be deduced: 1. The male: female ratio was 2∶1. This sharply contrasts to HCA of other origin which shows a strong female preponderance. 2. The histology of adenomas largely corresponded to other adenomas, except for the appearance of Mallory bodies, accompanied by neutrophilic inflammation and a peculiar lamellar fibrosis. This observation is of particular interest because Mallory bodies have so far not been described in adenomas but are a well established feature in hepatocellular carcinoma of any aetiology. 3. Adenomas had a tendency to regress after continuous nocturnal intragastric feeding, although not all cases responded favourably. 4. Ten cases of hepatocellular carcinoma (HCC) are recorded in GSD I in literature, whereby in half of them transition from HCA into HCC seems likely. 5. The similarity in clinical presentation and evolution with oestrogen-induced tumours is striking. Pathogenesis of adenoma formation in GSD I is not understood. Experimental evidence and the clinical observation of regression after correction of the metabolic imbalance suggest three possible candidate mechanisms: (1) a glucagon/insulin imbalance; (2) cellular glycogen overload; and (3) proto-oncogene activation. Evidence in favour of these three mechanisms from experimental studies and observations in humans are briefly reviewed.
Similar content being viewed by others
Abbreviations
- GSDI:
-
glycogen storage disease, type I
- HCA:
-
hepatocellular adenoma
- HCC:
-
hepatocellular carcinoma
- FNH:
-
focal nodular hyperplasia
- IGF:
-
(nocturnal) intragastric feeding
References
Bannasch P, Müller HA (1964) Lichtmikroskopische Untersuchung über die Wirkung von N-Nitrosomorpholin auf die Leber von Ratte und Maus. Arzneimittelforsch 14:805–814
Bannasch P, Mayer D, Hacker HJ (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 605:217–245
Bannasch P, Hacker HJ, Klimek F, Mayer D (1983) Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul 22:97–121
Bannasch P, Enzmann H, Hacker HJ, et al (1989) Comparative pathobiology of hepatic pre-neoplasia. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 55–76
Bianchi L (1983) Liver biopsy interpretation in hepatitis. Part I: presentation of critical morphologic features used in diagnosis (glossary). Path Res Pract 178:2–19
Biondetti PR, Fiore D, Muzzio PC (1980) Computed tomography of the liver in von Gierke's disease. J Comput Assist Tomogr 4:685–686
Bowerman RA, Samuels BI, Silver TM (1983) Ultrasonographic features of hepatic adenomas in type I glycogen storage disease. J Ultrasound Med 2:51–54
Brunelle F, Tammam S, Odièvre M, Chaumont P (1984) Liver adenomas in glycogen storage disease in children. Ultrasound and angiographic study. Pediatr Radiol 14:94–101
Brunn H, Schmidt E, Reinacher M, et al (1987) Histology and histochemistry of the liver of chickens after DEN-induced hepatocarcinogenesis and ingestion of low chlorinated biphenyls. Arch Toxicol 60:337–342
Bucher NLR, Swaffield MN (1975) Regulation of hepatic regeneration by synergistic action of insulin and glucagon. Proc Nat Acad Sci USA 72:1157–1160
Bucher NLR, Patel U, Cohen S (1978) Hormonal factors concerned with liver regeneration. In: Porter R, Whelan J (eds) Hepatotrophic factors. Elsevier, New York, pp 95–107
Bühler H, Pirovino M, Akovbiantz A, et al (1982) Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 82:775–782
Coire CI, Qizilbash AH, Castelli MF (1987) Hepatic adenomata in type Ia glycogen storage disease. Arch Path Lab Med 111:166–169
Couch JA, Courtney LA (1987) N-nitrosodiethylamine-induced hepatocarcinogenesis in estuarine sheephead minnow (Cyprinodon variegatus): Neoplasms and related lesions compared with mammalian lesions. J Nat Cancer Inst 79:297–321
Denk H (1984) The intermediate filament cytoskeleton in neoplastic and non-neoplastic liver disorders. J Submicr Cytol 16:141–145
Denk H, Franke WW, Kerjaschki D, Eckerstorfer R (1979) Mallory bodies in experimental animals and man. Int Rev Exp Path 20:77–121
Edmondson HA, Reynolds TB, Henderson B, Benton B (1977) Regression of liver cell adenomas associated with oral contraceptives. Ann Int Med 86:180–182
Farivar JR, Wands JR, Isselbacher KJ, et al (1976) Effect of insulin and glucagon in fulminant murine hepatitis. N Engl J Med 295:1517–1519
Fausto N (1990) Hepatic regeneration. In: Zakim D, Boyer TD (eds) Hepatology. Saunders, Philadelphia, pp 49–65
Fausto N, Mead J (1989) Regulation of liver growth: Protooncogenes and transforming growth factors. Lab Invest 60:4–13
Fink AS, Appleman HD, Thompson NW (1985) Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature. Surgery 97:117–123
Fischer G, Hartmann H, Droese M, et al (1986) Histochemical and immunohistochemical detection of putative preneoplastic liver foci in woman after long-term use of oral contraceptives. Virchows Arch Path Anat B 50:321–337
Fraumeni JF, Miller RW, Hill JA (1968) Primary carcinoma of the liver in childhood: an epidemiologic study. J Nat Cancer Inst 40:1087–1099
French SW (1983) Present understanding of the development of Mallory's body. Arch Path Lab Med 107:445–450
Fujiyama S, Sato K, Sakai M, et al (1990) a case of type Ia glycogen storage disease complicated by hepatic adenoma. Hepato-Gastroenterology 37:432–435
Greene HL (1982) Glycogen storage disease. Semin Liver Dis 2:291–301
Grossman H, Ram PC, Coleman RA, et al (1981) Hepatic ultrasonography in type I glycogen storage disease (van Gierke's disease): Detection of hepatic adenomas and carcinoma. Radiology 141:753–756
Holling HE (1963) Gout and glycogen storage disease. Ann Int Med 58:654–663
Howell RR, Stevenson RE, Ben-Menachem J, et al (1976) Hepatic adenomata with type 1 glycogen storage disease. J Am Med Assoc 236:1481–1484
Huber BE, Dearfield KL, Williams JR, et al (1985) Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line. Cancer Res 45: 4322–4329
Ishak KG (1979) Hepatic neoplasms associated with contraceptive and anabolic steroids. Recent Results Cancer Res 66: 73–128
Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59:995–1013
Ito E, Sato Y, Kawauchi K, et al (1987) Type Ia glycogen storage disease with hepatoblastoma in siblings. Cancer 59: 1776–1780
Karhunen PJ, Penttilä A (1987) Preneoplastic lesions in human liver. Hepato-Gastroenterol 34:10–15
Kharsa G, Degott C, Filoche B, et al (1990) Adenome hépatique et carcinome hépatocellulaire chez deux frères atteints de glycogenose de type I. Gastroenterol Clin Biol 14:84–89
Koch K, Leffert HL (1974) Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. VI. Studies with conditioned medium and its functional interactions with serum factors. J Cell Biol 62:780–791
Leffert HL, Koch KS, Moran T, Rubalcava B (1979) Hormonal control of rat liver regeneration. Gastroenterology 76: 1470–1482
Leffert HL, Koch KS, Lad PJ, et al (1982) Hepatocyte growth factors. In: Zakim D, Boyer TD (eds) Hepatology, Saunders, Philadelphia, pp 64–75
Leffert HL, Koch KS, Lad PJ, et al (1983) Glucagon and liver regeneration. In: Lefebvre P (ed) Handbook of experimental pharmacology. Springer, Berlin New York Heidelberg, pp 453–484
Leffert HL, Koch KS, Lad PJ, et al (1988) Hepatocyte regeneration, replication, and differentiation. In: Arias IM, Jacoby WB, Popper H, Schachter D, Shafritz DA (eds) The liver: biology and pathobiology, Raven Press, New York, pp 833–850
Limmer J, Fleig WE, Leupold D, et al (1988) Hepatocellular carcinoma in type I glycogen storage disease. Hepatology 8:531–537
Malatack JJ, Iwatsuki S, Gartner JC, et al (1983) Lancet I: 1073–1075
Mason HH, Andersen DH (1955) Glycogen disease of the liver (von Gierke's disease) with hepatomata: case report with metabolic studies. Pediatrics 16:785–799
Mayer D, Klimek F, Hacker HJ, et al (1989) Carbohydrate metabolism in hepatic pre-neoplasia. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 329–345
Miller JH, Gates GF, Landing BH, et al (1978) Scintigraphic abnormalities in glycogen storage disease. J Nucl Med 19:354–358
Moses SW (1991) Pathophysiology and dietary treatment of the glycogen storage diseases. J Pediat Gastroent Nutr (in press)
Motoo Y Nahmoudi M, Osther K, Bollon AP (1986) Oncogene expression in human hepatoma cells PLC/PRF/5. Biochim Biophys Res Commun 135:262–268
Nishio S, Oka T, Tanaka K, et al (1981) Type I glycogenosis with contracted kidneys and liver cell adenoma. Acta Pathol Jpn 31:873–881
Olàh E (1989) Pattern of oncogene expression in hepatoma cells. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 423–436
Olàh E, Natsumeda Y, Ikegami T, et al (1988) Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells. Proc Nat Acad Sci USA 85:6533–6537
Parker P, Burr I, Slonim A, et al (1981) Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. Gastroenterology 81:534–536
Pizzo CJ (1980) Type I glycogen storage disease with focal nodular hyperplasia of the liver and vasoconstrictive pulmonary hypertension. Pediatrics 65:341–343
Poe R, Snover DC (1988) Adenomas in glycogen storage disease type I. Two cases with unusual histologic features. Am J Surg Path 12:477–483
Ruckel A, Kubale R, Marg W (1990) Leberrundherde bei Glykogenose Typ I. Leber Magen Darm 20:158–161
Ruebner BH, Michas C, Kanayama R, Bannasch P (1976) Sequential hepatic histogenic and histochemical changes produced by diethylnitrosamine in the Rhesus monkey. J Nat Cancer Inst 57:1261–1268
Sell S, Osborn K, Leffert HL (1981) Autoradiography of oval cells appearing rapidly in the livers of rats fed N-2-fluorenyl-acetamide in choline-devoid diet. Carcinogenesis 2:7–14
Shimizu J, Shiraishi H, Sakurabayashi S et al (1982) A report on an adult case of type III glycogenosis with primary liver cancer and liver cirrhosis (in Japanese). Nippon Shokakibyo-Gakkai Zasshi 79:2328–2332
Shiomi S, Saeki Y, Kim K, et al (1989) A female case of type VIII glycogenosis who developed cirrhosis of the liver and hepatocellular tumor. Gastroenterol Jpn 24:711–714
Spycher AM, Gitzelmann R (1971) Glycogenosis type I (glucose-6-phosphatase deficiency): Ultrastructural alterations of hepatocytes in a tumor bearing liver. Virchows Arch B 8:133–142
Starzl TE, Terblanche J (1979) Hepatotrophic substances. In: Popper H, Schaffner F (eds) Prog Liver Dis vol VI; pp 135–151
Starzl TE, Porter KA, Kashiwagi N, Putnam CW (1975) Portal hepatotrophic factors, diabetes mellitus, and acute liver atrophy, hypertrophy, and regeneration. Surg Gynecol Obstet 141:843–858
Steinbrecher UB, Lisbona R, Huang SN, Mishkin S (1981) Complete regression of hepatocellular adenoma after with-drawal of oral contraceptives. Dig Dis Sci 26:1045–1050
Stenbäck F, Mori H, Furuya K, Williams GM (1986) Pathogenesis of dimethylnitrosamine-induced hepatocellular cancer in hamster liver and lack of enhancement by phenobarbital. J Nat Cancer Inst 76:327–333
Tricot GJ, Jayaram HN, Nichols CR, et al (1987) Hematological and biochemical action of tiazofurin in a case of refractory acute myeloid leukemia. Cancer Res 47:4988–4991
Vesselinovitch SD, Hacker HJ, Bannasch P (1985) Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice. Cancer Res 45: 2774–2780
Weber G (1968) Carbohydrate metabolism in cancer cells and the molecular correlation concept. Naturwissenschaften 55: 418–429
Weber G (1977) Enzymology of cancer cells N Engl J Med 296:486–493; 541–551
Weber G (1983) Biochemical strategy of cancer cells and the design of chemotherapy. Cancer Res 43:3466–3492
Weber G (1989) Biochemical strategy of hepatocellular carcinoma. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 361–374
Weber G, Jayaram HN, Lapis E, et al (1988) Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia. Adv Enzyme Regul 27:405–433
Zangeneh F, Limbeck GA, Brown BI, et al (1969) Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver. J Pediatr 74:73–83
Zhang XK, Huang DP, Chiu DK, Chiu JF (1987) The expression of oncogenes in human developing liver and hepatomas. Biochim Biophys Res Comm 142:932–938
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bianchi, L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr 152 (Suppl 1), 63–70 (1993). https://doi.org/10.1007/BF02072092
Issue Date:
DOI: https://doi.org/10.1007/BF02072092